Last month, Novo Nordisk won Food and Drug Administration approval for the first GLP-1 pill for weight loss. The medication, marketed as the Wegovy pill, is expected to be widely available this month.
A daily pill version of the weight-loss drug Wegovy shows significant weight reduction, greater convenience, and hope for making treatment accessible to millions of patients.
A study suggests twice-yearly Yeztugo offers HIV prevention without adversely affecting gender-affirming care.
Nodule and lipoma formation can occur rarely after an intramuscular influenza vaccination, particularly when administered ...
Prophylactic intramuscular vitamin K administration in newborns decreased from 2017 to 2024, according to a recent research ...
When the Trump administration slashed foreign aid, it gutted a program that had reduced malaria deaths world wide. In ...
HORSHAM, PA — Johnson & Johnson (NYSE: JNJ) has won U.S. Food and Drug Administration approval for RYBREVANT FASPRO, the ...
An overview of the top 10 stories from Optometry Times in 2025.
Dow Jones Top Energy Headlines at 12 AM ET: America's Biggest Oil Field Is Turning Into a Pressure Cooker | Trump's ... Drillers' injection of wastewater is creating mayhem across the Permian Basin, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback